Regulatory Updates
🇺🇸 FDA Page 22FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 253–264 of 373 articles
Oligonucleotide Therapeutics Market Size Report 2033: Clinical Trials Insights
NSF Announces Fourth Annual Pharma Biotech Conference 2026: Key Insights
FDA Restricts Large-Scale Compounding of Weight Loss Drugs
FDA Calendar 2026: Key Approval Dates and PDUFA Insights
Biotech IPOs Surge Amid M&A Activity: A New Era
Lifesaving Upgrades: 40 Years of FDA Oncology Approvals
China’s Licensing Boom: A Shift in Global Pharma Pipelines
SGS Acquires Keystone Bioanalytical: A Game Changer for Drug Development
Industry Groups Push for FDA Guidance Changes on Form 483 Responses
FDA Clarifies 3-Year Exclusivity Guidance: Key Insights
Mirum Maps FDA Path After Anti-Itch Candidate Scores Phase 2 Win
Astellas Faces Xtandi Patent Cliff: Strategic Moves Ahead